Merck Tbk. vs Tirta Mahakam Resources Tbk — how do they compare? Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume), while Tirta Mahakam Resources Tbk trades at Rp590 (market cap 657.65B, 520K 24h volume). The key difference: Merck Tbk. is far larger — about 2.7× Tirta Mahakam Resources Tbk's market cap, and Tirta Mahakam Resources Tbk is more actively traded (520K versus 63K). Which is the better fit depends on your goals.
| MERK | TIRT | |
|---|---|---|
Market Cap | 1.76T | 657.65B |
Volume | 63K | 520K |
Lot | 630 | 5.2K |
Turnover | 243.97M | — |
Average Price | 3,872.46 | — |
Value | 243.97M | — |
Indicative Equilibrium Price | 3,900 | — |
Indicative Equilibrium Volume | 1 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Tirta Mahakam Resources Tbk (The Company) was established based on Deed No. 245 dated April 22, 1981 jo. Revision deed No. 14 dated January 11, 1982, both of which were made in front of Notary Kartini Muljadi, SH. The Company started its commercial production in November 1983. The Companys domicilie is in South of Jakarta with its factories in Samarinda, East Kalimantan.
Read more on TIRT →